New guidelines are out that say many older adults with high blood pressure can be treated less aggressively. That could mean taking fewer pills to get high blood pressure under control.
The recommendations come from a government-appointed panel that reviewed rigorous research.for more information about health http://growtaller.thefanbase.net/
But government officials have not endorsed them and the American Heart Association is coming out with other guidelines next year.
Editor's Note: Video Exposes Dangers of Obamacare Law
Panel members stressed that they are not changing the definition of high blood pressure: article research by
http://michaelallen.photofolio.org/
140 over 90. But they say adults aged 60 and older don't need to take blood pressure drugs unless their levels reach 150 over 90 or higher.
The panel says treating older adults too aggressively can lead to fainting and falls.
The guidelines were released Wednesday in the Journal of the American Medical Association.
Read Latest Breaking News from Newsmax.com
Thursday, December 19, 2013
Painful Mosquito Virus Prompts CDC Warning
U.S. health officials have issued a travel advisory for the Caribbean island of St. Martin because of a mosquito-borne disease.
The Centers for Disease Control and Prevention says it's closely following reports of the chikungunya (chik-un-GUHN-ya) virus among residents of the French side of St. Martin.
The World Health Organization has reported 10 confirmed cases on the island. article research by http://dietfoods.singerprofile.net/
The CDC says it's the first time the disease has been reported among non-travelers in the Western Hemisphere. The virus can cause fever, joint pains, a rash, muscle aches and headaches. Travelers to St. Martin are advised to avoid mosquito bites by using insect repellent, go to for about health
http://sixpacksabs.lovescooking.net/
wearing long sleeves and pants, and to use air conditioning and window and door screens to keep mosquitoes out. Read Latest Breaking News from Newsmax.com
The CDC says it's the first time the disease has been reported among non-travelers in the Western Hemisphere. The virus can cause fever, joint pains, a rash, muscle aches and headaches. Travelers to St. Martin are advised to avoid mosquito bites by using insect repellent, go to for about health
http://sixpacksabs.lovescooking.net/
wearing long sleeves and pants, and to use air conditioning and window and door screens to keep mosquitoes out. Read Latest Breaking News from Newsmax.com
Flu Vaccine Linked to Narcolepsy
Scientists have found that the sleep disorder narcolepsy can sometimes be triggered by a scientific phenomenon known as "molecular mimicry," offering a possible explanation for its link to a GlaxoSmithKline H1N1 pandemic flu vaccine.
Results from U.S. researchers showed the debilitating disorder, characterized by sudden sleepiness and muscle weakness, can be set off by an immune response to a portion of a protein from the H1N1 virus that is very similar to a region of a protein called hypocretin, which is key to narcolepsy.
This can happen in genetically susceptible people, the researchers said, adding that around 20 percent of the European population have the genetic profile making them vulnerable. for more information about health http://weightloss.ismykitty.com/
Previous studies in countries where GSK's Pandemrix vaccine was used in the 2009/2010 flu pandemic have found its use was linked to a significant rise in cases of narcolepsy in children. Studies in Britain, Finland, Sweden and Ireland found such a link, and GSK says at least 900 narcolepsy cases associated with the vaccine have so far been reported in Europe. Narcolepsy is thought to be brought about by loss of function in "wakefulness" cells called hypocretin cells in one of the brain's sleep centres. for more details go to the link http://tipsforacne.ismypuppy.com/
CROSS-REACTIVITY
Emmanuel Mignot, a narcolepsy researcher and director of the Stanford Center for Sleep Sciences and Medicine who has been funded by GSK to look deeper into the link, said the relationship between H1N1 infection, vaccination and narcolepsy gave his team "some very interesting insight into possible causes of the condition."
In particular, he said, it strongly suggested that the defences, or T cells, of the immune system primed to attack H1N1 can occasionally also cross-react with hypocretin and somehow cause the destruction of brain cells that produce hypocretin.
"When we saw that the portion of the hypocretin that seemed to be recognised by the immune system in narcolepsy patients was similar to a part of the pandemic 2009 H1N1 influenza hemagglutinin molecule, we were very hopeful that we were on the right track," said Mignot's co-researcher Elizabeth Mellins, also at the Stanford University School of Medicine.
The Pandemrix vaccine mixed portions of viral proteins with a non-viral "adjuvant", or booster,
designed to induce a stronger immune response. The shot was never used in the United States and has been withdrawn from use in Europe since the links to narcolepsy emerged. The researchers said their study provided compelling evidence of "molecular mimicry" - the idea that because of a similarity between a pathogen protein and a human protein, the normal immune response to a pathogen, such as H1N1 flu, could in some people go awry, triggering the immune system to mistakenly attack healthy components of the body. Mignot said the findings, published in the journal Science Translational Medicine, could pave the way to a new blood test to diagnose narcolepsy. They also point towards potential new ways to try to intervene in narcolepsy before the specialised brain cells have been destroyed and led to the worst level of symptoms. "This study will shape the next decade of research into narcolepsy," Mellins said. Mignot, Mellins and their team now plan to study how T cell cross-reactivity to hypocretin can destroy the hypocretin cells in the brain, and whether this process could potentially be blocked to potentially prevent narcolepsy. Read Latest Breaking News from Newsmax.com http://www.newsmaxhealth.com/Health-News/flu-shot-vaccine-narcolepsy/2013/12/18/id/542656#ixzz2nuv0oQsY Alert: What Is Your Risk for a Heart Attack? Find Out Now
Previous studies in countries where GSK's Pandemrix vaccine was used in the 2009/2010 flu pandemic have found its use was linked to a significant rise in cases of narcolepsy in children. Studies in Britain, Finland, Sweden and Ireland found such a link, and GSK says at least 900 narcolepsy cases associated with the vaccine have so far been reported in Europe. Narcolepsy is thought to be brought about by loss of function in "wakefulness" cells called hypocretin cells in one of the brain's sleep centres. for more details go to the link http://tipsforacne.ismypuppy.com/
designed to induce a stronger immune response. The shot was never used in the United States and has been withdrawn from use in Europe since the links to narcolepsy emerged. The researchers said their study provided compelling evidence of "molecular mimicry" - the idea that because of a similarity between a pathogen protein and a human protein, the normal immune response to a pathogen, such as H1N1 flu, could in some people go awry, triggering the immune system to mistakenly attack healthy components of the body. Mignot said the findings, published in the journal Science Translational Medicine, could pave the way to a new blood test to diagnose narcolepsy. They also point towards potential new ways to try to intervene in narcolepsy before the specialised brain cells have been destroyed and led to the worst level of symptoms. "This study will shape the next decade of research into narcolepsy," Mellins said. Mignot, Mellins and their team now plan to study how T cell cross-reactivity to hypocretin can destroy the hypocretin cells in the brain, and whether this process could potentially be blocked to potentially prevent narcolepsy. Read Latest Breaking News from Newsmax.com http://www.newsmaxhealth.com/Health-News/flu-shot-vaccine-narcolepsy/2013/12/18/id/542656#ixzz2nuv0oQsY Alert: What Is Your Risk for a Heart Attack? Find Out Now
Weight-Loss Surgery Safe and Effective: Research Review
A new review finds that weight-loss surgery helps very obese patients drop pounds and improve their overall health, even if there is some risk for complications.
"We've gotten good at doing this," said Dr. Mitchell Roslin, chief of weight-loss surgery at Lenox Hill Hospital in New York City. "Bariatric surgery has become one of the safest intra-abdominal major procedures."
"The question is why we don't start facing the facts," said Roslin, who was not involved in the new review. "If the data were this good with any other condition, the standard of care for morbid obesity would be surgery."
Roslin said he thinks a bias against obesity tinges the way people look at weight-loss surgery.
"People don't view obesity as a disease, and blame the victim," he said. "We have this ridiculous notion that the next diet is going to be effective -- although there has never been an effective diet for people who are severely obese."
Morbid obesity is a chronic condition that is practically irreversible and needs to be treated aggressively, Roslin said. for more information about health
http://exercises.creativist.me/
"The only treatment that's effective is surgery," he said. Review author Su-Hsin Chang is an instructor in the division of public health services at the Washington University School of Medicine, in St. Louis. "Weight-loss surgery provides substantial effects on weight loss and improves obesity-related conditions in the majority of bariatric patients, although risks of complication, reoperation and [death] exist," Chang said. "Death rates are, in general, very low." "The extent of weight loss and risks are different across different procedures," she said. "These should be well communicated when the surgical option is offered to obese patients and should be well considered when making decisions." The report was published online Dec. read for more details visit my web page http://causeseczema.isthephotographer.com/
18 in the journal JAMA Surgery. For the study, Chang's team analyzed more than 150 studies related to weight-loss surgery. More than 162,000 patients, with an average body-mass index (BMI) of nearly 46, were included. BMI is a measure of body fat based on height and weight, and a BMI of more than 40 is considered very severely obese. Overall, complication rates ranged from 10 percent to 17 percent and the reoperation rate was about 7 percent. http://yeastinfection.doesphotography.com/
The death rate ranged from .08 percent to .31 percent. However, the operation improved obesity-related conditions, such as diabetes, high blood pressure and sleep apnea. Five years after the operation, the reduction in BMI ranged from 12 to 17 points. The review showed differences between the types of weight-loss procedures. For example, gastric bypass was more effective for weight loss but was associated with more complications. In gastric bypass,
part of the stomach is closed off to prevent the patient from eating too much. In adjustable gastric banding, in which a band is used to reduce the size of the stomach, the death and complication rates were lower but reoperation rates were higher. In addition, weight loss with gastric banding was less than with gastric bypass, the researchers found. Among all the procedures, sleeve gastrectomy appeared to result in the most weight loss, the researchers said. In this procedure, a large part of the stomach is removed, reducing it to about 25 percent of its original size. This results in a sleeve or tube-like structure.
Roslin said common complications include bleeding, infection and bowel blockage. Roslin said everyone who has a BMI over 35 and has sleep apnea, severe heart failure or needs insulin for type 2 diabetes should consider having bariatric surgery. "Every patient who needs a joint replacement [and has] a BMI greater than 40 should consider bariatric surgery," he added. Read Latest Breaking News from Newsmax.com
http://exercises.creativist.me/
"The only treatment that's effective is surgery," he said. Review author Su-Hsin Chang is an instructor in the division of public health services at the Washington University School of Medicine, in St. Louis. "Weight-loss surgery provides substantial effects on weight loss and improves obesity-related conditions in the majority of bariatric patients, although risks of complication, reoperation and [death] exist," Chang said. "Death rates are, in general, very low." "The extent of weight loss and risks are different across different procedures," she said. "These should be well communicated when the surgical option is offered to obese patients and should be well considered when making decisions." The report was published online Dec. read for more details visit my web page http://causeseczema.isthephotographer.com/
18 in the journal JAMA Surgery. For the study, Chang's team analyzed more than 150 studies related to weight-loss surgery. More than 162,000 patients, with an average body-mass index (BMI) of nearly 46, were included. BMI is a measure of body fat based on height and weight, and a BMI of more than 40 is considered very severely obese. Overall, complication rates ranged from 10 percent to 17 percent and the reoperation rate was about 7 percent. http://yeastinfection.doesphotography.com/
The death rate ranged from .08 percent to .31 percent. However, the operation improved obesity-related conditions, such as diabetes, high blood pressure and sleep apnea. Five years after the operation, the reduction in BMI ranged from 12 to 17 points. The review showed differences between the types of weight-loss procedures. For example, gastric bypass was more effective for weight loss but was associated with more complications. In gastric bypass,
part of the stomach is closed off to prevent the patient from eating too much. In adjustable gastric banding, in which a band is used to reduce the size of the stomach, the death and complication rates were lower but reoperation rates were higher. In addition, weight loss with gastric banding was less than with gastric bypass, the researchers found. Among all the procedures, sleeve gastrectomy appeared to result in the most weight loss, the researchers said. In this procedure, a large part of the stomach is removed, reducing it to about 25 percent of its original size. This results in a sleeve or tube-like structure.
Roslin said common complications include bleeding, infection and bowel blockage. Roslin said everyone who has a BMI over 35 and has sleep apnea, severe heart failure or needs insulin for type 2 diabetes should consider having bariatric surgery. "Every patient who needs a joint replacement [and has] a BMI greater than 40 should consider bariatric surgery," he added. Read Latest Breaking News from Newsmax.com
FDA OKs New COPD Drug
A new inhaled drug to treat a serious lung condition called chronic obstructive pulmonary disease (COPD) has been approved by the U.S. Food and Drug Administration.
GlaxoSmithKline's Anoro Ellipta is meant to be used once a day for long-term maintenance of airflow in patients with COPD. The lung disease makes breathing difficult and worsens over time.
"Anoro Ellipta works by helping the muscles around the airways of the lungs stay relaxed to increase airflow in patients with COPD," Dr. Curtis Rosebraugh, director of the Office of Drug Evaluation II in the FDA's Center for Drug Evaluation and Research, said in an agency news release.
"The availability of new long-term maintenance medications provides additional treatment options for the millions of Americans who suffer with COPD," he added. http://articles.al.lv/article.php?id=244565
Dr. Len Horovitz, a pulmonary specialist at Lenox Hill Hospital in New York City, said the new medication is a "unique combination" of two drugs presently used for COPD. "It combines a drug similar to Spiriva and a [long-acting beta agonist] as found in Advair, he said. "There is no steroid in Anoro Ellipta." According to the FDA, Anoro Ellipta combines umeclidinium, a drug that prevents muscles around the large airways from tightening, and vilanterol, which improves breathing by relaxing the muscles of the airways to allow more air to flow into and out of the lungs. Another lung specialist, http://calories.blooming.me/
Dr. Charles Powell, called the approval a "promising development for patients with COPD," noting other countries already allow this type of medication. "Combined long-acting bronchodilators are available in Europe. Now we have the first approved combined long-acting bronchodilator medication available in the U.S.," said Powell, who is chief of pulmonary, critical care and sleep medicine at the Mount Sinai - National Jewish Health Respiratory Institute in New York City. " http://dietfoods.likeapro.me/
Combining two effective bronchodilators can result in improved lung function and medication compliance compared to traditional COPD inhaled medications," Powell said. The FDA approval is based on findings from more than 2,400 people with COPD. The results showed that those who took the drug had greater improvements in lung function than those who took a placebo. The most common side effects reported by patients who took Anoro Ellipta included sore throat, sinus infection, lower respiratory tract infection, constipation, diarrhea, pain in extremities, muscle spasms,
neck pain and chest pain. Serious side effects that can be caused by the drug include narrowing and obstruction of the airway, cardiovascular effects, increased pressure in the eyes, and worsening of urinary retention. Anoro Ellipta is not approved for asthma treatment and should not be used as a rescue treatment for sudden breathing problems, the FDA said. The drug carries a boxed warning that the class of drugs that vilanterol belongs to increases the risk of asthma-related death. "Patients with COPD need to be seen and examined before determining the appropriate use of this drug, as with any medication," added Horovitz. Cigarette smoking is the main contributor to COPD, which is the third leading cause of death in the United States. Symptoms can include chest tightness, chronic cough and excessive phlegm. Read Latest Breaking News from Newsmax.com http://www.newsmaxhealth.com/Health-News/Anoro-Ellipta-copd-drug/2013/12/18/id/542661#ixzz2nuteCoPu Alert: What Is Your Risk for a Heart Attack? Find Out Now
Dr. Len Horovitz, a pulmonary specialist at Lenox Hill Hospital in New York City, said the new medication is a "unique combination" of two drugs presently used for COPD. "It combines a drug similar to Spiriva and a [long-acting beta agonist] as found in Advair, he said. "There is no steroid in Anoro Ellipta." According to the FDA, Anoro Ellipta combines umeclidinium, a drug that prevents muscles around the large airways from tightening, and vilanterol, which improves breathing by relaxing the muscles of the airways to allow more air to flow into and out of the lungs. Another lung specialist, http://calories.blooming.me/
Dr. Charles Powell, called the approval a "promising development for patients with COPD," noting other countries already allow this type of medication. "Combined long-acting bronchodilators are available in Europe. Now we have the first approved combined long-acting bronchodilator medication available in the U.S.," said Powell, who is chief of pulmonary, critical care and sleep medicine at the Mount Sinai - National Jewish Health Respiratory Institute in New York City. " http://dietfoods.likeapro.me/
Combining two effective bronchodilators can result in improved lung function and medication compliance compared to traditional COPD inhaled medications," Powell said. The FDA approval is based on findings from more than 2,400 people with COPD. The results showed that those who took the drug had greater improvements in lung function than those who took a placebo. The most common side effects reported by patients who took Anoro Ellipta included sore throat, sinus infection, lower respiratory tract infection, constipation, diarrhea, pain in extremities, muscle spasms,
neck pain and chest pain. Serious side effects that can be caused by the drug include narrowing and obstruction of the airway, cardiovascular effects, increased pressure in the eyes, and worsening of urinary retention. Anoro Ellipta is not approved for asthma treatment and should not be used as a rescue treatment for sudden breathing problems, the FDA said. The drug carries a boxed warning that the class of drugs that vilanterol belongs to increases the risk of asthma-related death. "Patients with COPD need to be seen and examined before determining the appropriate use of this drug, as with any medication," added Horovitz. Cigarette smoking is the main contributor to COPD, which is the third leading cause of death in the United States. Symptoms can include chest tightness, chronic cough and excessive phlegm. Read Latest Breaking News from Newsmax.com http://www.newsmaxhealth.com/Health-News/Anoro-Ellipta-copd-drug/2013/12/18/id/542661#ixzz2nuteCoPu Alert: What Is Your Risk for a Heart Attack? Find Out Now
Future Directions in ADHD
Although no actual cure is in sight, a new compassionate of absorption arrears ataxia (ADHD) may be forthcoming. Using a array of analysis accoutrement and methods, scientists are alpha to bare new advice on the role of the academician in ADHD and able treatments for the ataxia Such analysis will ultimately aftereffect in convalescent the claimed accomplishment and abundance of bodies with ADHD.For example, the use of new techniques like academician imaging to beam how the academician absolutely works is already accouterment new insights into the causes of ADHD. Added analysis is gluttonous to analyze altitude of abundance and aboriginal adolescence that may account or accord to these differences in the brain. As the anatomy of ability grows, scientists may anytime apprentice how to anticipate these differences or at atomic how to amusement them read for more details visit my web page http://memoto.es/article.php?id=69057
.Researchers are additionally aggravating to actuate if there are altered varieties of absorption deficit. With added study, advisers may acquisition that ADHD absolutely covers a cardinal of altered disorders, anniversary with its own array of affection and analysis requirements. For example, scientists are exploring whether there are any analytical differences amid accouchement with ADHD who additionally accept anxiety, depression, or conduct disorders and those who do not. Added advisers are belief slight concrete differences that ability analyze one blazon of ADHD from another. If clusters of differences can be found, scientists can activate to analyze the analysis anniversary blazon needs.Future ADHD MedicationsA new biologic with a nonstimulant apparatus of activity may be accustomed in 2009 for the analysis of attention-deficit/hyperactivity ataxia (ADHD). Intuniv (guanfacine extended-release tablets) is a careful alpha2A-agonist in development by Shire for the once-daily analysis of ADHD. article research by
http://www.articlesempire.com/article.php?id=20313
The aggregation submitted an NDA for monotherapy for the analysis of ADHD affection throughout the day in accouchement age-old 6 to 17 years and accustomed an approvable letter from the FDA in June 2007.The FDA requested added information, and the aggregation has been administering added analytic assignment accompanying to the drug’s label.Immediate-release guanfacine, a medication acclimated to amusement aerial claret pressure, additionally is acclimated off-label in ADHD.Anticipated advantages of Intuniv over guanfacine accommodate FDA approval accurately for ADHD and aliment of claret absorption in the ameliorative range, which is ambiguous with immediate-release formulations.
Accession abeyant advantage: Intuniv is not a controlled substance, and is not associated with any accepted mechanisms for abeyant corruption or dependence.An estimated 30% of accouchement with ADHD cannot abide analeptic drugs or do not account from currently accessible ADHD medications. Intuniv additionally ability accept applications in aggregate with analeptic drugs to abate assailment and indisposition associated with stimulants and developed patients. Shire hopes to accretion FDA approval and barrage Intuniv in the additional bisected of 2009.Additional Analysis into ADHDAdditional analysis is analytical the abiding aftereffect of ADHD. How do accouchement with ADHD about-face out, compared to brothers and sisters after the disorder?
As adults, how do they handle their own children? Still added studies seek to bigger accept ADHD in adults. Such studies accord insights into what types of analysis or casework accomplish a aberration in allowance an ADHD adolescent abound into a caring ancestor and a well-functioning adult.Animal studies are additionally abacus to our ability of ADHD in humans.
Beastly capacity accomplish it accessible to abstraction some of the accessible causes of ADHD in means that can’t be advised in people. In addition, beastly analysis allows the assurance and capability of alpha new drugs to be activated continued afore they can be accustomed to humans. One NIH-sponsored aggregation of scientists is belief dogs to apprentice how new analeptic drugs that are agnate to Ritalin act on the brain.Piece by piece, through studies of bodies and animals, scientists are alpha to accept the biological attributes of absorption disorders. New analysis is acceptance us to bigger accept the close apparatus of the academician as we abide to advance new medications and appraise new forms of treatment.
.Researchers are additionally aggravating to actuate if there are altered varieties of absorption deficit. With added study, advisers may acquisition that ADHD absolutely covers a cardinal of altered disorders, anniversary with its own array of affection and analysis requirements. For example, scientists are exploring whether there are any analytical differences amid accouchement with ADHD who additionally accept anxiety, depression, or conduct disorders and those who do not. Added advisers are belief slight concrete differences that ability analyze one blazon of ADHD from another. If clusters of differences can be found, scientists can activate to analyze the analysis anniversary blazon needs.Future ADHD MedicationsA new biologic with a nonstimulant apparatus of activity may be accustomed in 2009 for the analysis of attention-deficit/hyperactivity ataxia (ADHD). Intuniv (guanfacine extended-release tablets) is a careful alpha2A-agonist in development by Shire for the once-daily analysis of ADHD. article research by
http://www.articlesempire.com/article.php?id=20313
The aggregation submitted an NDA for monotherapy for the analysis of ADHD affection throughout the day in accouchement age-old 6 to 17 years and accustomed an approvable letter from the FDA in June 2007.The FDA requested added information, and the aggregation has been administering added analytic assignment accompanying to the drug’s label.Immediate-release guanfacine, a medication acclimated to amusement aerial claret pressure, additionally is acclimated off-label in ADHD.Anticipated advantages of Intuniv over guanfacine accommodate FDA approval accurately for ADHD and aliment of claret absorption in the ameliorative range, which is ambiguous with immediate-release formulations.
Accession abeyant advantage: Intuniv is not a controlled substance, and is not associated with any accepted mechanisms for abeyant corruption or dependence.An estimated 30% of accouchement with ADHD cannot abide analeptic drugs or do not account from currently accessible ADHD medications. Intuniv additionally ability accept applications in aggregate with analeptic drugs to abate assailment and indisposition associated with stimulants and developed patients. Shire hopes to accretion FDA approval and barrage Intuniv in the additional bisected of 2009.Additional Analysis into ADHDAdditional analysis is analytical the abiding aftereffect of ADHD. How do accouchement with ADHD about-face out, compared to brothers and sisters after the disorder?
As adults, how do they handle their own children? Still added studies seek to bigger accept ADHD in adults. Such studies accord insights into what types of analysis or casework accomplish a aberration in allowance an ADHD adolescent abound into a caring ancestor and a well-functioning adult.Animal studies are additionally abacus to our ability of ADHD in humans.
Beastly capacity accomplish it accessible to abstraction some of the accessible causes of ADHD in means that can’t be advised in people. In addition, beastly analysis allows the assurance and capability of alpha new drugs to be activated continued afore they can be accustomed to humans. One NIH-sponsored aggregation of scientists is belief dogs to apprentice how new analeptic drugs that are agnate to Ritalin act on the brain.Piece by piece, through studies of bodies and animals, scientists are alpha to accept the biological attributes of absorption disorders. New analysis is acceptance us to bigger accept the close apparatus of the academician as we abide to advance new medications and appraise new forms of treatment.
Getting Help for Attention Deficit Disorder
Where does one turn when they suspect their child is suffering from attention deficit disorder (ADHD)?
Most families first turn to their family physician or pediatrician for help, which is often a good first step. However, a reliable diagnosis of ADHD is best made by a trained and experienced mental health professional who specializes in helping children with ADHD. Such professionals are usually child psychologists, child psychiatrists, as well as some developmental or behavioral pediatricians and behavioral neurologists. Clinical social workers may also have such training. article research http://www.1500dollarwebsite.com/article.php?id=350722
While some pediatricians may do the assessment themselves, parents should always ask for a referral to an appropriate mental health specialist. In addition, state and local agencies that serve families and children, as well as some of the volunteer organizations listed at the end of this document, can help identify appropriate specialists.Knowing the differences in qualifications and services can help the family choose someone who can best meet their needs. read for more details visit my web page http://www.article-galaxy.com/article.php?id=22043
There are several types of specialists qualified to diagnose and treat ADHD. Child psychiatrists are doctors who specialize in diagnosing and treating childhood mental and behavioral disorders. A psychiatrist can provide therapy and prescribe any needed medications. Child psychologists are also qualified to diagnose and treat ADHD. They can provide therapy for the child and help the family develop ways to deal with the disorder. But psychologists are not medical doctors and must rely on the child’s physician to do medical exams and prescribe medication. for more details go to the link
http://konkanmail.com/article/article.php?id=339993
Neurologists, doctors who work with disorders of the brain and nervous system, can also diagnose ADHD and prescribe medicines. But unlike psychiatrists and psychologists, neurologists usually do not provide therapy for the emotional aspects of the disorder. Within each specialty, individual doctors and mental health professionals differ in their experiences with ADHD. So in selecting a specialist, it’s important to find someone with specific training and experience in diagnosing and treating the disorder.
While some pediatricians may do the assessment themselves, parents should always ask for a referral to an appropriate mental health specialist. In addition, state and local agencies that serve families and children, as well as some of the volunteer organizations listed at the end of this document, can help identify appropriate specialists.Knowing the differences in qualifications and services can help the family choose someone who can best meet their needs. read for more details visit my web page http://www.article-galaxy.com/article.php?id=22043
There are several types of specialists qualified to diagnose and treat ADHD. Child psychiatrists are doctors who specialize in diagnosing and treating childhood mental and behavioral disorders. A psychiatrist can provide therapy and prescribe any needed medications. Child psychologists are also qualified to diagnose and treat ADHD. They can provide therapy for the child and help the family develop ways to deal with the disorder. But psychologists are not medical doctors and must rely on the child’s physician to do medical exams and prescribe medication. for more details go to the link
http://konkanmail.com/article/article.php?id=339993
Neurologists, doctors who work with disorders of the brain and nervous system, can also diagnose ADHD and prescribe medicines. But unlike psychiatrists and psychologists, neurologists usually do not provide therapy for the emotional aspects of the disorder. Within each specialty, individual doctors and mental health professionals differ in their experiences with ADHD. So in selecting a specialist, it’s important to find someone with specific training and experience in diagnosing and treating the disorder.
Subscribe to:
Comments (Atom)